Minimal (min) i maximal (max) biochemical markers of participants in Group 1b indicate that values are within the expected range. Larger values of the coefficient of variation (Cv) indicate that there is heterogeneity of Group 1b in terms of: OC1 (OC1) (50.16), CL1 (CL1) (59.96). Increased values of Skewness indicate that distribution is negatively asymmetric which means that distribution results curve
tends toward larger values, i.e., there are larger values in comparison to normal
distribution in: OC1 (OC1) (.11), CL1 (CL1) (.22). Negative values of Curtosis
indicate that curve is flattened at: OC1 (OC1) (-1.12), CL1 (CL1) (-.35).Value
distribution range mostly within normal distribution (p) at: OC1 (OC1) (.80), CL1
(CL1) (.73)
Minimal (min) i maximal (max) biochemical markers of participants in Group 2b indicate that values are within the expected range. Larger values of the coefficient of variation (Cv) indicate that there is heterogeneity of Group 2b in terms of: OC1 (OC1) (38.19), CL1 (CL1) (46.81). Increased values of Skewness indicate that distribution is negatively asymmetric which means that distribution results curve
tends toward larger values, i.e., there are larger values in comparison to normal
distribution in: OC1 (OC1) (.33), CL1 (CL1) (.35). Negative values of Curtosis
indicate that the curve is flattened at: OC1 (OC1) (.08). Value distribution range
mostly within normal distribution (p) at: OC1 (OC1) (.66), CL1 (CL1) (.88) |
||||||||||||||||||||||||||||||||||||||||||

Table 10: Central and dispersed parameters and asymmetry and flattening
measures of laboratory parameters during the therapy, done in groups. (N=178). |